|
May 13
|
Should Value Investors Buy Teva Pharmaceutical Industries (TEVA) Stock?
|
|
May 9
|
TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up
|
|
May 9
|
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2024 Earnings Call Transcript
|
|
May 9
|
Affirm stock sinking, Good Buy or Goodbye: Market Domination
|
|
May 9
|
Teva Pharmaceutical Industries First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
May 9
|
Teva and Medincell report positive data for TEV-‘749 in schizophrenia trial
|
|
May 8
|
Teva Pharma's Turnaround Story: How A Key Win Helped It Clinch A Five-Year High
|
|
May 8
|
Teva Pharmaceutical Industries (TEVA) Q1 2024 Earnings Call Transcript
|
|
May 8
|
Teva Pharmaceutical Industries (TEVA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
|
|
May 8
|
REFILE-UPDATE 1-Teva Pharm Q1 profit misses estimates, revenue rises
|
|
May 8
|
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
|
|
May 8
|
Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook
|
|
May 8
|
Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia
|
|
May 7
|
Teva Earnings Are Soon. What Could Keep the Stock Gains Going.
|
|
May 7
|
20 States with the Highest Fertility Rates in the US
|
|
May 6
|
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
|
|
May 6
|
Teva Pharmaceutical Industries (NYSE:TEVA) shareholders have earned a 54% return over the last year
|
|
May 3
|
A Week Of Fast-Moving Stocks Ahead: Disney, Toyota, Ferrari, Constellation
|
|
May 3
|
Unlocking Q1 Potential of Teva Pharmaceutical Industries (TEVA): Exploring Wall Street Estimates for Key Metrics
|
|
May 2
|
Teva to Present at the 2024 Bank of America Healthcare Conference
|